COVID-19 and NMDs – Latest news

On this page we will attempt to collate all the information we receive or find out about on the virus COVID-19 and the implications it has on the neuromuscular community.

We will try to keep this page as up to date as possible but as you can appreciate developments sometime happen very quickly in circumstances such as this so we cannot guarantee this.

If you read an article of interest we strongly recommend you then follow the link provided to the ‘source of the information’ to ensure it is indeed completely up to date.

If you feel we may have missed something from this section of the website please get in touch with your suggestion info@ern-euro-nmd.eu


Guidelines COVID-19 – For Wheelchair Users

Date : 21 May 2020
Disease : Neuromuscular disease

Guidelines COVID-19 – For caregivers at home

Date : 21 May 2020
Disease : Neuromuscular disease

Guidelines COVID-19 – Orthopaedic physiotherapy Tutorial for caregivers

Date : 21 May 2020
Disease : Neuromuscular disease

EURO-NMD Board Meeting 2020 moves to online format

Date : 14 April 2020
Disease : Neuromuscular disease

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Date : 6 April 2020
Disease : Neuromuscular disease

COVID-19 and Neuromuscular Patients

Date : 1 April 2020
Disease : Neuromuscular disease

Pulmonary Support for Myotonic Dystrophy Patients During COVID-19 Pandemic

Date : 1 April 2020
Disease : Myotonic dystrophy, Myotonic dystrophy type 1, Myotonic dystrophy type 2

COVID-19: Care Recommendations for Home-Based Ventilation Patients

Date : 1 April 2020
Disease : Amyotrophic lateral sclerosis, Myotonic dystrophy, Myotonic dystrophy type 1, Myotonic dystrophy type 2, Duchenne muscular dystrophy, Spinal muscular atrophy

Guidance for the management of Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS)

Date : 30 March 2020
Disease : Lambert-Eaton Myasthenic Syndrome, Myasethenia gravis

EU Commission launches “COVID-19 Clinical Management Support System”

Date : 30 March 2020
Disease : Neuromuscular disease

Coronavirus: ALERT on the use of chloroquine in myasthenia gravis

Date : 30 March 2020
Disease : Myasthenia Gravis

COVID-19 advice for the NMD community – UPDATED

Date : 25 March 2020
Disease : Neuromuscular disease

Translational Summer School 2020 – Postponed!

Date : 25 March 2020
Disease : Neuromuscular disease

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern